| PDE 5 inhibitors, sildenafil and vardenafil, reverse multidrug resistance by inhibiting the efflux function of multidrug resistance protein 7 (ATP‐binding Cassette C 10 … JJ Chen, YL Sun, AK Tiwari, ZJ Xiao, K Sodani, DH Yang, SG Vispute, ... Cancer science 103 (8), 1531-1537, 2012 | 59 | 2012 |
| Fibroblast growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor (AhR) X Cheng, SG Vispute, J Liu, C Cheng, A Kharitonenkov, CD Klaassen Toxicology and applied pharmacology 278 (1), 65-71, 2014 | 46 | 2014 |
| Esters of the marine-derived triterpene sipholenol A reverse P-GP-mediated drug resistance Y Zhang, YK Zhang, YJ Wang, SG Vispute, S Jain, Y Chen, J Li, ... Marine drugs 13 (4), 2267-2286, 2015 | 25 | 2015 |
| Activation of GR but not PXR by dexamethasone attenuated acetaminophen hepatotoxicities via Fgf21 induction SG Vispute, P Bu, Y Le, X Cheng Toxicology 378, 95-106, 2017 | 22 | 2017 |
| Comprehensive nonclinical safety assessment of nirmatrelvir supporting timely development of the SARS-COV-2 antiviral therapeutic, Paxlovid™ JG Sathish, S Bhatt, JK DaSilva, D Flynn, S Jenkinson, AS Kalgutkar, ... International Journal of Toxicology 41 (4), 276-290, 2022 | 15 | 2022 |
| Vemurafenib (PLX4032, Zelboraf®), a BRAF inhibitor, modulates ABCB1-, ABCG2-, and ABCC10-mediated multidrug resistance SG Vispute, JJ Chen, YL Sun, KS Sodani, S Singh, Y Pan, T Talele, ... Journal of Cancer Research Updates 2 (4), 306-317, 2013 | 11 | 2013 |
| Experiments in the EpiDerm 3D skin in vitro model and minipigs in vivo indicate comparatively lower in vivo skin sensitivity of topically applied aneugenic compounds M Schuler, L Tomlinson, M Homiski, J Cheung, Y Zhan, S Coffing, ... Toxicological Sciences 180 (1), 103-121, 2021 | 6 | 2021 |
| An orthogonal methods assessment of topical drug concentrations in skin and the impact for risk assessment in the viable epidermis BD Hollingshead, L Tomlinson, J Finley, C Doshna, C Ritenour, ... Regulatory Toxicology and Pharmacology 123, 104934, 2021 | 3 | 2021 |
| Cross study analyses of SEND data: toxicity profile classification MA Carfagna, CS Ahmed, S Butler, T Fukushima, W Houser, N Jensen, ... Toxicological Sciences 200 (2), 277-286, 2024 | | 2024 |
| Characterization of Regulation and Function of Fibroblast Growth Factor (FGF) 21 SG Vispute St. John's University, 2016 | | 2016 |
| Esters of the marine-derived triterpene sipholenol a reverse P-GP-mediated drug resistance. ZYC Zhang YongChao, ZYK Zhang YunKai, WYJ Wang YiJun, ... | | 2015 |
| Fibroblast Growth Factor (Fgf) 21 is a Novel Target Gene of Glucocorticoid Receptor S Vispute, P Bu, Y Le, X Cheng The FASEB Journal 29, 619.5, 2015 | | 2015 |
| Asset creation for sustainable development: a conscious strategy for enhancing livelihoods security and quality of life. SG Vispute, VV Kulkarni, PP Thipsay | | 2014 |
| Fibroblast growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor (AhR). CXG Cheng XingGuo, SG Vispute, LJ Liu Jie, C Cheng, A Kharitonenkov, ... | | 2014 |
| 33rd ANNUAL GRASP CONFERENCE NY QUEENS | | 2014 |
| Tyrosine kinase inhibitors are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance K Sodani, YH Kuang, T Shen, S Vispute, AK Tiwari, Y Lei, J Lee, X Chen, ... Cancer Research 70 (8_Supplement), 1519-1519, 2010 | | 2010 |
